China News Service, Changsha, October 30 (Fu Jingyi) China's first domestic intelligent laboratory management platform (ILP) was released on the 30th in Changsha, Hunan.
Gu Jinhui, deputy director of the Department of Science and Education of the National Health Commission of China, said that as one of the core achievements of the "13th Five-Year Major New Drug Creation" science and technology project "Pharmacgenomics-based Clinical Evaluation Technology Platform for Exemplary New Drugs", ILP will open China The road to comprehensive informationization of pharmaceutical research and development.
Drug R&D laboratories are the core position of drug R&D. At present, China's domestic laboratories have a large number of paper records, information islands, and traceability problems; at the same time, the domestic laboratory information system has a low degree of specialization, a single functional structure, and laboratory information. The market is in a dilemma of being monopolized by foreign manufacturers.
In the current changing international situation, the localization of key technologies and core software is imminent.
Industry personnel experience the smart laboratory management platform.
Image courtesy of Tongnuo Information
The ILP released this time was created by Changsha Tongnuo Information Technology Co., Ltd., combining leading technologies such as 5G, cloud computing, big data, artificial intelligence, and integrating the information management system P-harmLIMS, scientific data management system-SDMS and The electronic experiment record book-PharmELN is integrated, which can provide a total solution for the information management of drug research and development.
"The platform is based on the Internet of Things, breaking through the limitations of the existing information platform Internet thinking." Ouyang Dongsheng, a professor at Xiangya Hospital of Central South University and founder of Tongnuo Information, said that the scientific data management system can break through the communication protocol and automatically collect information from different vendors. Instrument data, the beginning of the infinite charm of the Internet of everything in the laboratory; blockchain and other high-tech blessings can ensure the traceability of the whole process, so that the technology is endorsed by integrity; the one-click generation of experimental reports will greatly improve the efficiency of laboratory management.
According to calculations by technicians, the efficiency of laboratories using ILP will increase by 60%, which will reduce R&D costs while ensuring quality.
At the same time, the platform strictly complies with regulatory requirements to ensure that the data is true, complete, accurate, and traceable, and inject new technological driving force into pharmaceutical research and development.
“The drug regulatory department is very pleased to witness the advent of products such as the smart laboratory management platform ILP.” Zeng Linggui, deputy director of the Hunan Provincial Drug Administration, said that ILP can not only ensure the authenticity, completeness, accuracy and traceability of the data, but also hope to achieve One-click review of drug R&D, clinical, supply chain and circulation.
It is reported that Changsha Tongnuo Information Technology Co., Ltd., established in 2017, focuses on the information construction of pharmacy and clinical research, and is committed to providing comprehensive information technology solutions for domestic and foreign pharmaceutical companies, scientific research institutions and government agencies. At present, Tongnuo Information has successfully passed the ISO9001 certification and the "Double Software Certification", and the quality management system and service standardization and accuracy have reached the international advanced level. (Finish)